Virtus Biotech ETF BBP
Last price
104.88
USD
Change: Up +2.50
Percent change: Up +2.44%
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.34%
- Net assets
- $98.5M
- Holdings
- 70
- 12-month distribution yield
- Unavailable
- Asset class
- Equity
Virtus Biotech ETF (BBP) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Virtus. Its category is Equity · Global (equity). Its last price was US$104.88 on 20 Oct 2026. Its expense ratio is 0.34% a year, from its prospectus dated 27 Feb 2026. It reported net assets of US$98.54 million as of 31 Jul 2026. Its latest holdings report lists 70 holdings as of 31 Jul 2026. No distributions are recorded for it over the last 12 months.
General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.
Fees
- Total annual operating expenses (gross)
- 0.34%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.34%
- Prospectus date
- 27 Feb 2026
- Filed with the SEC
- 27 Feb 2026
Size and reporting
- Net assets
- $98,543,965
- Total assets
- $99,269,083
- Holdings as of
- 31 Jul 2026
- Report made public
- 29 Sep 2026 (60 days after the month end)
Top holdings
Largest 25 of 70 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS INC CRINETICS PHARMACEUTICALS INC COM | US22663K1079 | 3.34% | $3.3M | Equity (common) | United States | USD |
| 2 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | GB00BRXB0C07 | 1.97% | $1.9M | Equity (common) | United Kingdom | USD |
| 3 | VERASTEM INC VERASTEM INC COM NEW | US92337C2035 | 1.95% | $1.9M | Equity (common) | United States | USD |
| 4 | PRECIGEN INC PRECIGEN INC COM | US74017N1054 | 1.94% | $1.9M | Equity (common) | United States | USD |
| 5 | OMEROS CORP OMEROS CORP COM | US6821431029 | 1.87% | $1.8M | Equity (common) | United States | USD |
| 6 | NUVATION BIO INC NUVATION BIO INC COM CL A | US67080N1019 | 1.77% | $1.7M | Equity (common) | United States | USD |
| 7 | REGENERON PHARMACEUTICALS REGENERON PHARMACEUTICALS INC | US75886F1075 | 1.72% | $1.7M | Equity (common) | United States | USD |
| 8 | PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC COM | US74366E1029 | 1.71% | $1.7M | Equity (common) | United States | USD |
| 9 | ACADIA PHARMACEUTICALS INC ACADIA PHARMACEUTICALS INC COM | US0042251084 | 1.69% | $1.7M | Equity (common) | United States | USD |
| 10 | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM | US10806X1028 | 1.65% | $1.6M | Equity (common) | United States | USD |
| 11 | BEONE MEDICINES LTD BEONE MEDICINES LTD SPONSORED ADS | US07725L1026 | 1.65% | $1.6M | Equity (common) | Switzerland | USD |
| 12 | XERIS BIOPHARMA HOLDINGS INC XERIS BIOPHARMA HOLDINGS INC COM | US98422E1038 | 1.64% | $1.6M | Equity (common) | United States | USD |
| 13 | HALOZYME THERAPEUTICS INC | US40637H1095 | 1.64% | $1.6M | Equity (common) | United States | USD |
| 14 | LIQUIDIA CORP LIQUIDIA CORP COM NEW | US53635D2027 | 1.63% | $1.6M | Equity (common) | United States | USD |
| 15 | IMMUNOCORE HOLDINGS PLC IMMUNOCORE HOLDINGS PLC ADS | US45258D1054 | 1.61% | $1.6M | Equity (common) | United Kingdom | USD |
| 16 | IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC COM CL A | US46333X1081 | 1.60% | $1.6M | Equity (common) | United States | USD |
| 17 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 1.56% | $1.5M | Equity (common) | United States | USD |
| 18 | ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD SHS | BMG762791017 | 1.55% | $1.5M | Equity (common) | Bermuda | USD |
| 19 | LIGAND PHARMACEUTICALS LIGAND PHARMACEUTICALS INC | US53220K5048 | 1.55% | $1.5M | Equity (common) | United States | USD |
| 20 | RHYTHM PHARMACEUTICALS INC RHYTHM PHARMACEUTICALS INC COM | US76243J1051 | 1.55% | $1.5M | Equity (common) | United States | USD |
| 21 | GERON CORP GERON CORP COM | US3741631036 | 1.54% | $1.5M | Equity (common) | United States | USD |
| 22 | RIGEL PHARMACEUTICALS INC RIGEL PHARMACEUTICALS INC COM | US7665597024 | 1.54% | $1.5M | Equity (common) | United States | USD |
| 23 | ASCENDIS PHARMA A/S ASCENDIS PHARMA A/S ORD SHS | DK0060615755 | 1.54% | $1.5M | Equity (common) | Denmark | USD |
| 24 | ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC COM | US03969K1088 | 1.52% | $1.5M | Equity (common) | United States | USD |
| 25 | INCYTE CORP | US45337C1027 | 1.52% | $1.5M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.80% | |
| Short-term investment vehicles (cash funds) | 0.71% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 84.60% | |
| Cayman Islands | 3.58% | |
| United Kingdom | 3.58% | |
| Switzerland | 2.97% | |
| Bermuda | 1.55% | |
| Denmark | 1.54% | |
| Germany | 1.38% | |
| Canada | 1.30% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.51% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 52.82% | |
| Health Technology | 3.34% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
No distributions in the last five years
Yahoo Finance lists no distributions for BBP since October 2021. Funds that reinvest income, and new funds, may have none.
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000047354) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- BBP and VT Vanguard Total World Stock Index ETF
- BBP and SMH VanEck Semiconductor ETF
- BBP and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- BBP and CGDV Capital Group Dividend Value ETF